Rate My Professor Nadom Safi

Dr Nadom Safi is a public health researcher and epidemiologist with extensive experience in the management and analysis of linked population health data. He serves as an Honorary Lecturer in the School of Medicine and Public Health within the College of Health, Medicine and Wellbeing at the University of Newcastle. Holding a PhD in Public Health from the University of Technology Sydney, a Master of Public Health from the University of New South Wales, a Bachelor of Medicine and Bachelor of Surgery from Almustansiriya University, and a Diploma in Rheumatology and Rehabilitation from the University of Baghdad, Iraq, Dr Safi is an overseas-qualified doctor with 16 years of clinical experience. He commenced his research career in 2015 and has since contributed to various NHMRC-funded projects, developing expertise in leading and managing research initiatives.

Dr Safi's research focuses on epidemiology, perinatal outcomes, and pregnancy-associated cancer, with fields of research encompassing obstetrics and gynaecology (40%), oncology and carcinogenesis (40%), and epidemiology (20%). He currently manages a project funded by the Cancer Council NSW that evaluates outcomes for women diagnosed with pregnancy-associated cancer and their infants using ten linked population health and mortality datasets from New South Wales. His career includes prior roles as Research Fellow at the University of Newcastle from October 2020 to December 2022 and Research Officer at the University of Technology Sydney from June 2015 to September 2020. Key publications include "Haematological cancer in pregnancy in New South Wales, Australia: A population-based retrospective cohort study" (2026, Cancer Epidemiology), "In situ and localized primary invasive pregnancy-associated melanoma: Maternal and perinatal outcomes" (2025, Journal of the European Academy of Dermatology and Venereology), "Perinatal outcomes for infants exposed to systemic cancer treatment during gestation: A systematic review and meta-analysis" (2025, BMJ Open), "Pregnancy-associated gynecological cancer in New South Wales, Australia 1994-2013: A population-based historical cohort study" (2024, Acta Obstetricia et Gynecologica Scandinavica), "Pregnancy associated cancer, timing of birth and clinical decision making: a NSW data linkage study" (2023, BMC Pregnancy and Childbirth), and "In utero exposure to breast cancer treatment: a population-based perinatal outcome study" (2019, British Journal of Cancer).